The Association between Angiotensin Receptor Blocker Usage and Breast Cancer Characteristics

Publisher： Karger

E-ISSN： 1423-0232|91|4|217-223

ISSN： 0030-2414

Source： Oncology, Vol.91, Iss.4, 2016-08, pp. : 217-223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association of the Vitamin D Receptor Genotype with Bone Metastases in Breast Cancer Patients

By  

Oncology, Vol. 64, Iss. 2, 2003-02 ,pp. : 154-159

Karger

Access to resources Recommend Favorite

Treatment of angiotensin receptor blocker‐induced Angioedema: A case series

By  

THE LARYNGOSCOPE, Vol. 125, Iss. 7, 2015-07 ,pp. : 1619-1623

John Wiley & Sons Inc

Access to resources Recommend Favorite

Calcium Channel Blocker versus Angiotensin II Receptor Blocker in Autosomal Dominant Polycystic Kidney Disease

By  

Nephron Clin Pract, Vol. 99, Iss. 1, 2005-01 ,pp. : c18-c23

Karger

Access to resources Recommend Favorite

Receptor Expression Discrepancy between Primary and Metastatic Breast Cancer Lesions

By  

Oncology Research and Treatment, Vol. 37, Iss. 11, 2014-10 ,pp. : 622-626

Karger

Access to resources Recommend Favorite

Association between Statin Usage and Prostate Cancer Prevention: A Refined Meta-Analysis Based on Literature from the Years 2005-2010

By  

Urologia Internationalis, Vol. 90, Iss. 3, 2012-10 ,pp. : 259-262

Karger

Access to resources Recommend Favorite